Plastic waste degradation has led to an increase in nanoplastics, which can cross biological barriers and disrupt immune function, potentially triggering inflammatory and autoimmune conditions. A systematic review was conducted following PRISMA 2020 guidelines. Literature from PubMed, Embase, Scopus, and Cochrane Library (2015–2025) was screened for in vitro and in vivo studies investigating nanoplastic-induced immune responses, with data extraction and quality assessment performed by independent reviewers. Ten studies met inclusion criteria. Both in vitro and in vivo evidence demonstrated that nanoplastic exposure induces oxidative stress, cytokine imbalance, and activation of pro-inflammatory pathways, resulting in tissue-specific cellular damage across multiple organs. Nanoplastic exposure is linked to significant immune modulation and inflammation, indicating potential public health risks. Further long-term, standardized research is needed to elucidate the role of nanoplastics in autoimmune diseases such as lichen planus and to inform regulatory policies.

Background/Objectives: Oral candidiasis is an opportunistic infection caused by Candida species. Recently, antifungal drugs have become less effective due to yeast resistance, emphasizing the need for new treatment strategies. This study aimed to assess the effect of the Er:YAG laser on the inhibition of growth and elimination of mature single-species Candida biofilms. Methods: The study utilized reference strains of C. albicans, C. glabrata, C. parapsilosis, and C. krusei organized in single-species biofilms on Sabouraud dextrose agar (SDA). First part: Candida suspensions (0.5 McFarland standard) were spread on SDA plates—two for each strain. Er:YAG laser irradiation was applied in a single pulse mode, 30 to 400 mJ, to 32 predetermined points. The growth inhibition zones (GIZs) were measured at 24–96 h of incubation. Second part: biofilms were prepared similarly and, after 96 h of incubation, exposed to Er:YAG laser irradiation at different energies (50, 100, 150, 200 mJ) for 180 s, per 1.44 cm area. Post-irradiation, impressions were taken using Rodac Agar to determine yeast counts. The count of colony-forming units (CFU) after irradiation was measured and results were analysed statistically. Results: First part: GIZ was found in all irradiated sites, with various Candida strains. The results showed a significant increase in the width of GIZ in the energy range of 30–280 mJ and a non-significant increase in the energy range of 300–400 mJ. Second part: the number of CFU remaining after the irradiation of biofilms with 150 mJ energy differed statistically significantly from other results obtained after using 50, 100, or 200 mJ energy, regardless of the Candida strain tested. Conclusions: The Er:YAG is shown to have good disinfecting properties (inhibiting biofilm growth, even at low-energy doses (50 mJ), and eliminating maturity, Candida spp. biofilms most effective on the 150 mJ energy dose).

The relevance of the current study is to increase the resistance of fungal biofilms to traditional disinfection methods. The aim of the study was to determine how effectively Er:YAG laser light inhibits single-species Candida biofilms. The study involved a systematic review of 57 scientific publications (2015–2024) selected according to specific criteria, followed by an assessment of quantitative and qualitative indicators of colony-forming unit reduction. The results show that under optimal parameters (power 1.5–3.9 W and duration 60–90 s), the Er:YAG laser can reduce the number of viable Candida albicans cells by an average of 70–90%, and when combined with sodium hypochlorite or chlorhexidine solutions, this figure can exceed 90%. Separate in vitro tests show that Candida glabrata and Candida tropicalis require higher power or longer exposure to achieve a similar effect, while the use of the Er:YAG laser on titanium and dental surfaces minimizes damage to the substrate and effectively removes the biofilm matrix. In addition, laser treatment accelerates tissue regeneration and helps reduce the number of cases of reinfection, which is confirmed by the positive dynamics in clinical practice. Data analysis using confocal microscopy and microbiological seeding indicates a significant disruption of the biofilm structure and increased permeability to antimycotics after laser exposure. Er:YAG laser disinfection method is promising in counteracting fungal biofilms, especially for surfaces with a high risk of microbial colonization. The practical value lies in the possibility of developing standard protocols for the clinical use of the laser, which will increase the effectiveness of treatment and prevention of Candidal lesions.

(1) Background: This study aimed to compare alveolar bone preservation and early healing outcomes following a comprehensive laser-assisted post-extraction protocol compared to conventional extraction alone. In addition, the potential influence of serum vitamin D levels on bone regeneration was assessed. (2) Methods: Thirty tooth extractions were performed and randomized into two groups: a test group (G1, n =15) and a control group (G2, n = 15). G1 received a laser-assisted protocol using Er:YAG and Nd:YAG lasers for granulation tissue removal, socket disinfection, clot stabilization, de-epithelialization, and photobiomodulation (PBM) with the Genova handpiece (LightWalker, Fotona, Slovenia). G2 underwent standard mechanical extractions and socket debridement without laser. (3) Results: Procedures in G1 were on average 8.7 min longer, but patients in this group reported significantly lower postoperative pain during the first three days (p < 0.05). A statistically significant difference in alveolar height was observed at the distal lingual site (25.4 mm vs. 21.7 mm; p = 0.046), with other sites showing a trend toward significance. Cumulative bone preservation, measured by Bone Loss Index (BLI4), was significantly better in the laser group. Notably, a positive correlation was found between serum vitamin D levels and bone preservation: each 1 ng/mL increase in vitamin D corresponded to a 0.18 mm gain in alveolar height (p = 0.021). (4) Conclusions: The comprehensive laser-assisted post-extraction protocol reduced postoperative pain and improved alveolar bone preservation, particularly at the lingual distal site. Serum vitamin D levels positively correlated with healing outcomes, suggesting a potential synergistic role of systemic and local regenerative factors.

Background: Snoring and mild to moderate obstructive sleep apnoea (OSA) are common sleep-related breathing disorders with increasing demand for minimally invasive treatment options. This study aimed to systematically evaluate the efficacy and safety of erbium:yttrium–aluminium–garnet (Er:YAG) laser therapy for these conditions. Methods: A systematic review and meta-analysis were conducted in line with PRISMA guidelines. Studies published between 2015 and 2025 were retrieved from major biomedical databases based on predefined inclusion criteria. Data were extracted on treatment outcomes, laser parameters, patient characteristics, and adverse effects. Results: Fifty-six studies were included. Er:YAG laser treatment, particularly in non-ablative SMOOTH and long-pulse modes, significantly reduced snoring intensity and improved subjective sleep quality. High patient satisfaction (65–85%) and a favourable safety profile were observed, with adverse effects generally mild and transient. Therapeutic effects typically lasted 12–24 months, though 25–40% of patients required maintenance sessions. Treatment success was associated with BMI, oropharyngeal anatomy, smoking status, and baseline apnoea-hypopnoea index scores (AHI 5–30 events/hour). Conclusions: Er:YAG laser therapy appears to be a safe and effective short- to medium-term treatment for selected patients with snoring or mild to moderate OSA. Optimising patient selection and treatment protocols may enhance long-term outcomes. Based on moderate-quality evidence for the immediate effects and safety profile, but low to very low quality evidence for long-term outcomes, erbium:yttrium–aluminium–garnet laser treatment appears to be a potentially effective and well-tolerated option for achieving short- to medium-term improvement in carefully selected patients with primary snoring or mild to moderate obstructive sleep apnoea. The practical significance of these findings lies in the refinement of candidate selection criteria, laser parameter settings, and the development of optimal protocols for long-term snoring control.

Background: High-energy laser systems may offer oncologic control with fewer complications in OSCC. Methods: Following PRISMA 2020, 30 studies were synthesized. Effect sizes were pooled as HR, OR, or SMD, with 95% CIs using inverse variance methods. Fixed effects were used when I² ≤ 50, random effects otherwise. Risk of bias was assessed with RoB 2 and ROBINS-I. Results: Compared with conventional surgery, laser resection was associated with lower local recurrence (OR 0.58, 95% CI 0.43 to 0.77, I² 47, random effects), higher 3-year overall survival (HR 0.72, 95% CI 0.55 to 0.94, I² 22, fixed effects), and fewer intraoperative complications (OR 0.29, 95% CI 0.18 to 0.47, I² 39, random effects). Quality of life favored lasers at 3 months (SMD 0.61, 95% CI 0.38 to 0.84, I² 66, random effects). Upon subgroup analysis, CO₂ and Er,Cr:YSGG showed the most consistent benefits. Risk of bias was commonly low for sequence generation and reporting, but high for blinding due to the surgical context. Several cohorts were observational with potential confounding. Funnel plots and Egger tests did not indicate major small-study effects for the primary outcomes. Conclusions: High-energy lasers, particularly CO₂ and Er,Cr:YSGG, are associated with improved oncologic and functional outcomes versus conventional surgery. Given the study heterogeneity, limited RCTs, and risks of bias, these findings should be interpreted with caution and confirmed in standardized, multicenter randomized trials. The protocol is registered with PROSPERO (CRD420251119822).